Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Non-interventional Surveillance Pharmacoepidemiology Study (PMSS) to Evaluate Long-term Safety, Tolerability and Compliance in Administration of Xyrem® (Sodium Oxybate) Oral Solution in Patients Who Receive Treatment With This Medication in Regular Clinical Practice.

NCT00244465 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00244465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00244465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Non-interventional Surveillance Pharmacoepidemiology Study (PMSS) to Evaluate Long-term Safety, Tolerability and Compliance in Administration of Xyrem® (Sodium Oxybate) Oral Solution in Patients Who Receive Treatment With This Medication in Regular Clinical Practice.
Lead sponsor
UCB Pharma
Phase
Observational
Overall status
Completed
Start date
May 31, 2006
Completion date
September 30, 2016
Enrollment
750 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

narcolepsy